| PC | Pancreatic cancer |
| OSCC | Oral squamous-cell carcinoma |
| 5-ALA | 5-aminolevulinic acid |
| PpIX | Protoporphyrin IX |
| PDT | Photodynamic therapy |
| ROS | Reactive oxygen species |
| ALAD | ALADENT |
| HGF-1 | Human gingival fibroblast |
| FECH | Ferrochelatase |
| HClO4 | Perchloric acid |
| Control | CTRL |
| MED | Minimum effective dose |
| PL | Poloxamer |
| SD | Standard deviation |
| ANOVA | Analysis of variance |
| PI | Propidium iodide |
| FITC | Fluorescein-isothiocyanate |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| FBS | Fetal bovine serum |
| TLR | Toll-like receptor |
| AlGaAs | Aluminium gallium arsenide |
| FHWM | Full width half maximum |
| CM-H2DCFDA | 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester |